KIT and colorectal cancer: Further studies found c-Kit expression in 59% of stage II colorectal cancer patients [60], in 90% of normal colon mucosa and 30% of neoplastic tissues [61] and in 15% of primary colorectal tumors and 14% of distant metastases [62].